89bio, Inc. (ETNB)
Oct 30, 2025 - ETNB was delisted (reason: acquired by RHHBY)
14.84
0.00 (0.00%)
Inactive · Last trade price on Oct 29, 2025
89bio Employees
89bio had 93 employees as of December 31, 2024. The number of employees increased by 23 or 32.86% compared to the previous year.
Employees
93
Change (1Y)
23
Growth (1Y)
32.86%
Revenue / Employee
n/a
Profits / Employee
-$4,840,925
Market Cap
2.31B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 93 | 23 | 32.86% |
| Dec 31, 2023 | 70 | 25 | 55.56% |
| Dec 31, 2022 | 45 | 4 | 9.76% |
| Dec 31, 2021 | 41 | 14 | 51.85% |
| Dec 31, 2020 | 27 | 7 | 35.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
ETNB News
- 9 days ago - 3 Investable Laggards In An Overbought Market - Seeking Alpha
- 18 days ago - My Top 3 Pharma Stocks - Seeking Alpha
- 4 weeks ago - 89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB - Business Wire
- 7 weeks ago - 3 Potential Biotech Acquisition Targets - Seeking Alpha
- 7 weeks ago - 89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB - Business Wire
- 7 weeks ago - Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push - Benzinga
- 7 weeks ago - Roche to Buy 89bio for Up to $3.5 Billion - WSJ
- 7 weeks ago - Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters